Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan

Trial Profile

Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Jan 2017

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 10 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 15 Apr 2015 Planned End Date changed from 1 Dec 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov
    • 15 Apr 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top